GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Cxcl3 | multiple interactions | EXP | | 6480464 | CTD | [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CXCL3 mRNA | PMID:33729688 | Cxcl3 | increases expression | ISO | Cxcl3 (Mus musculus) | 6480464 | CTD | Oxygen results in increased expression of CXCL1 mRNA | PMID:22363622 | Cxcl3 | multiple interactions | ISO | Cxcl3 (Mus musculus) | 6480464 | CTD | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CXCL1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CXCL3 mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of CXCL1 protein; [POSTN gene mutant form results in decreased susceptibility to Oxygen] which results in decreased expression of CXCL1 mRNA; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of CXCL1 protein]; PARP1 gene mutant form inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of CXCL1 protein]; POSTN gene mutant form inhibits the reaction [Oxygen results in increased expression of CXCL1 mRNA] | PMID:15696051 PMID:22363622 PMID:30529165 | | ||||||||||||||||||||||
| Go Back to source page | Continue to Ontology report |